Search results
Showing 706 to 720 of 2042 results for guidelines
Awaiting development [GID-QS10094] Expected publication date: TBC
A quick guide to creating a safeguarding culture
Signatera for detecting molecular residual disease from solid tumour cancers (MIB307)
NICE has developed a medtech innovation briefing (MIB) on Signatera for detecting molecular residual disease from solid tumour cancers .
Supporting the health and care system to implement virtual wards
resources to help manage ARI patients safely in their homes. Clinical Guideline: Acute Respiratory Infection in over 16s: Initial...
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)
Evidence-based recommendations on using immunohistochemistry or microsatellite instability testing to guide further testing for Lynch syndrome in people with colorectal cancer
Help us improve NICE: take part in research to help us develop better products and services.
LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis (MIB317)
NICE has developed a medtech innovation briefing (MIB) on LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis .
Learn from NICE International, part of the UK’s National Institute for Health and Care Excellence, about how to improve your nation’s health and wellbeing
The NICE public health guidance development process (third edition) (PMG5)
The NICE public health guidance development process (third edition)
Show all sections
- 1 Introduction
- 2 Topic selection
- 3 The guidance development processes
- 4 The role of stakeholders in the guidance development process
- 5 The role of the Public Health Advisory Committees (PHACs) in the development of public health guidance
- 6 The role of evidence providers
- 7 The role of the CPHE project team
- 8 Fieldwork
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia (ES37)
Summary of the evidence on delafloxacin for community-acquired pneumonia in adults
In development [GID-QS10113] Expected publication date: TBC
NICE decision aid: process guide
Evidence-based recommendations on semaglutide (Wegovy) for managing overweight and obesity in adults.
In development [GID-TA10571] Expected publication date: 26 March 2025
Evidence based recommendations on patiromer (Veltassa) for treating hyperkalaemia in adults.